NewsDialy
An 8-K, the mandatory SEC disclosure companies file when executive leadership changes, confirmed that STAAR Surgical (NASDAQ: STAA) has named Warren Foust its permanent President and Chief Executive Officer, effective August 4, 2026.
The appointment ends roughly six months of shared interim leadership, during which Foust and Chief Financial Officer Deborah Andrews held co-CEO duties simultaneously.
Andrews retains the CFO role and gains a new Executive Vice President title. From interim to permanent The transition at STAAR was less a dramatic reset than a formalization of what was already in place.
Foust joined the Lake Forest, California company in April 2023 as Chief Operating Officer, moved to President and COO in March 2025, and was named Interim Co-CEO in February 2026.
Keep reading